iguratimod has been researched along with Spondylitis, Ankylosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Deng, Y; Fan, J; Hao, W; He, Q; Long, Z; Yang, K; Zeng, L | 1 |
| Cui, Y; Liu, S; Zhang, X | 1 |
2 review(s) available for iguratimod and Spondylitis, Ankylosing
| Article | Year |
|---|---|
Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials.
Topics: Chromones; Humans; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Sulfonamides | 2023 |
Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis.
Topics: Chromones; Humans; Quality of Life; Spondylitis, Ankylosing; Sulfonamides | 2021 |